The North America Syphilis Testing Market would witness market growth of 5.1% CAGR during the forecast period (2022-2028).
Syphilis is the only sexually transmitted infection (STI) for which a low-cost, quick complete blood count is available. This test is already being used in several resource-constrained contexts. The test is accurate, may yield findings in 15 to 20 minutes, and is easy to use. Rapid syphilis testing has been shown to aid in the detection of pregnant women with the disease, as these women do not have much time to cure it before giving birth and have a high chance of passing it on to their children. However, in most low- and middle-income countries, additional effort is needed to ensure that all pregnant women are tested for syphilis. Several rapid diagnostics for various STIs are being developed, with the potential to enhance STI diagnosis and treatment, especially in resource-limited conditions.
The rise in syphilis incidence and prevalence rates is a major element driving market expansion for syphilis testing. In the MSM (Men who have sex with men) population, injecting drug users, and sex workers, there are a growing number of new illnesses being spread. Furthermore, many cases of syphilis are asymptomatic during the infectious phase and hence go undetected.
Despite the availability of efficient therapies and formerly effective prevention techniques, syphilis has seen a major resurgence in the United States in the recent decade. The majority of cases occur among males who have sex with men (MSM); nevertheless, there has been a recent surge among premenopausal women, which coincides with an alarming increase in congenital cases. Syphilis' reappearance can be linked in part to shifting social and behavioral variables, particularly among young MSM.
The increasing individual and healthcare burden, the biological link between syphilis and human immunodeficiency virus (HIV) transmission and infection is particularly concerning. Furthermore, some individual acts and public health efforts aimed at reducing the risk of contracting HIV may instead result in risk compensation, making syphilis transmission easier. Because untreated syphilis is linked to negative health outcomes, both effective prevention and treatment measures for this systemic illness have significant short- and long-term implications for health.
The US market dominated the North America Syphilis Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $389.4 million by 2028. The Canada market is anticipated to grow at a CAGR of 7.5% during (2022 - 2028). Additionally, The Mexico market would experience a CAGR of 6.6% during (2022 - 2028).
Based on Type, the market is segmented into Primary & Secondary Syphilis and Others. Based on Location of Testing, the market is segmented into Laboratory testing and Point of care (POC) testing. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Syphilis Testing Market is Estimated to reach $1.5 Billion by 2028, at a CAGR of 5.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Siemens Healthineers AG, Abbott Laboratories, DiaSorin S.p.A. (Luminex Corporation), Hologic, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Danaher Corporation (Cepheid), and F. Hoffmann-La Roche Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Primary & Secondary Syphilis
- Others
By Location of Testing
- Laboratory testing
- Point of care (POC) testing
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Siemens Healthineers AG
- Abbott Laboratories
- DiaSorin S.p.A. (Luminex Corporation)
- Hologic, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Danaher Corporation (Cepheid)
- F. Hoffmann-La Roche Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Syphilis Testing Market, by Type
1.4.2 North America Syphilis Testing Market, by Location of Testing
1.4.3 North America Syphilis Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Syphilis Testing Market by Type
3.1 North America Primary & Secondary Syphilis Market by Country
3.2 North America Others Market by Country
Chapter 4. North America Syphilis Testing Market by Location of Testing
4.1 North America Laboratory testing Market by Country
4.2 North America Point of care (POC) testing Market by Country
Chapter 5. North America Syphilis Testing Market by Country
5.1 US Syphilis Testing Market
5.1.1 US Syphilis Testing Market by Type
5.1.2 US Syphilis Testing Market by Location of Testing
5.2 Canada Syphilis Testing Market
5.2.1 Canada Syphilis Testing Market by Type
5.2.2 Canada Syphilis Testing Market by Location of Testing
5.3 Mexico Syphilis Testing Market
5.3.1 Mexico Syphilis Testing Market by Type
5.3.2 Mexico Syphilis Testing Market by Location of Testing
5.4 Rest of North America Syphilis Testing Market
5.4.1 Rest of North America Syphilis Testing Market by Type
5.4.2 Rest of North America Syphilis Testing Market by Location of Testing
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Danaher Corporation (Cepheid)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Becton, Dickinson and Company
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Thermo Fisher Scientific, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Bio-Rad laboratories, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expenses
6.6 Hologic, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent Strategies and Developments:
6.6.5.1 Approvals and Trials:
6.7 DiaSorin S.p.A. (Luminex Corporation)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expenses
6.8 Abbott Laboratories
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent Strategies and Developments:
6.8.5.1 Approvals and Trials:
6.9 Siemens Healthineers AG (Siemens AG)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expenses
TABLE 1 North America Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 2 North America Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 3 North America Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 4 North America Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 5 North America Primary & Secondary Syphilis Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Primary & Secondary Syphilis Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 10 North America Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 11 North America Laboratory testing Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Laboratory testing Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Point of care (POC) testing Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Point of care (POC) testing Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Syphilis Testing Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Syphilis Testing Market by Country, 2022 - 2028, USD Million
TABLE 17 US Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 18 US Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 19 US Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 20 US Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 21 US Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 22 US Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 23 Canada Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 24 Canada Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 25 Canada Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 26 Canada Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 27 Canada Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 28 Canada Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 29 Mexico Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 30 Mexico Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 31 Mexico Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 32 Mexico Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 33 Mexico Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 34 Mexico Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 35 Rest of North America Syphilis Testing Market, 2018 - 2021, USD Million
TABLE 36 Rest of North America Syphilis Testing Market, 2022 - 2028, USD Million
TABLE 37 Rest of North America Syphilis Testing Market by Type, 2018 - 2021, USD Million
TABLE 38 Rest of North America Syphilis Testing Market by Type, 2022 - 2028, USD Million
TABLE 39 Rest of North America Syphilis Testing Market by Location of Testing, 2018 - 2021, USD Million
TABLE 40 Rest of North America Syphilis Testing Market by Location of Testing, 2022 - 2028, USD Million
TABLE 41 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 42 Key Information – Danaher Corporation
TABLE 43 Key information – Becton, Dickinson and Company
TABLE 44 Key Information – Thermo Fisher Scientific, Inc.
TABLE 45 Key Information – Bio-Rad Laboratories, Inc.
TABLE 46 Key information – Hologic, Inc.
TABLE 47 Key Information – DiaSorin S.p.A.
TABLE 48 Key Information – Abbott Laboratories
TABLE 49 Key Information – Siemens Healthineers AG
List of Figures
FIG 1 Methodology for the research